Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI
- PMID: 32463295
- PMCID: PMC7446019
- DOI: 10.1259/bjr.20200195
Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI
Abstract
Objective: To compare the efficacy of contrast-enhanced ultrasound enabled reclassification of Breast Imaging Reporting and Data System (CEUS-BI-RADS) with MRI in the diagnosis of breast lesions with calcification.
Methods: A total of 52 breast lesions with calcification from 51 patients were detected by ultrasound as hyperechoic foci and categorized as BI-RADS 3-5. The 51 patients further underwent CEUS scan and MRI. The ultrasound-BI-RADS combined with CEUS 5-point score system redefined the classification of BI-RADS which was called CEUS-BI-RADS. The diagnostic efficacy of three methods was assessed by receiver operating characteristic (ROC) curve analysis. Histopathological assessment used as the gold-standard.
Results: The sensitivities of Ultrasound-BI-RADS, MRI classification of BI-RADS (MRI-BI-RADS) and CEUS-BI-RADS were 85%, 90% and 95% without significant difference among the three modalities (p > 0.05). The diagnostic specificities of ultrasound-BI-RADS, MRI-BI-RADS and CEUS-BI-RADS were 78.1%, 78.1% and 96.8%, respectively (p < 0.05); and the accuracy were 80.7%, 82.6% and 96.1% for ultrasound-BI-RADS, MRI-BI-RADS and CEUS-BI-RADS, respectively (p < 0.05). The area under ROC (AUROC) in differentiation of breast lesions with calcification was 0.945 for CEUS-BI-RADS, 0.907 for MRI-BI-RADS and 0.853 for ultrasound-BI-RADS, with no significant difference among the three modalities (p > 0.05).
Conclusion: The CEUS-BI-RADS has a better diagnostic efficiency than MRI-BI-RADS in the differentiation of the breast lesions with calcification.
Advances in knowledge: •CEUS is a better method in differentiation of breast lesions with calcification.•CEUS-BI-RADS increases the efficiency of diagnosis compared to MRI.
Figures



Similar articles
-
Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.Eur Radiol. 2017 Jun;27(6):2443-2450. doi: 10.1007/s00330-016-4628-4. Epub 2016 Oct 19. Eur Radiol. 2017. PMID: 27761708
-
The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging.Br J Radiol. 2022 Aug 1;95(1136):20220025. doi: 10.1259/bjr.20220025. Epub 2022 May 30. Br J Radiol. 2022. PMID: 35604699 Free PMC article.
-
Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications.Clin Radiol. 2020 Dec;75(12):934-941. doi: 10.1016/j.crad.2020.07.017. Epub 2020 Aug 16. Clin Radiol. 2020. PMID: 32814625
-
Third-look contrast-enhanced ultrasonography plus needle biopsy for differential diagnosis of magnetic resonance imaging-only detected breast lesions.J Med Ultrason (2001). 2024 Oct;51(4):599-604. doi: 10.1007/s10396-023-01298-8. Epub 2023 Mar 11. J Med Ultrason (2001). 2024. PMID: 36905491 Free PMC article. Review.
-
The added value of contrast-enhanced ultrasound to conventional ultrasound in differentiating benign and malignant solid breast lesions: a systematic review and meta-analysis.Clin Radiol. 2018 Nov;73(11):936-943. doi: 10.1016/j.crad.2018.06.004. Epub 2018 Jul 6. Clin Radiol. 2018. PMID: 30297035
Cited by
-
The value of contrast-enhanced ultrasound versus shear wave elastography in differentiating benign and malignant superficial lymph node lesions.Am J Transl Res. 2021 Oct 15;13(10):11625-11631. eCollection 2021. Am J Transl Res. 2021. PMID: 34786088 Free PMC article.
-
Head-to-head comparison of perfluorobutane contrast-enhanced US and multiparametric MRI for breast cancer: a prospective, multicenter study.Breast Cancer Res. 2023 May 30;25(1):61. doi: 10.1186/s13058-023-01650-3. Breast Cancer Res. 2023. PMID: 37254149 Free PMC article.
-
Application of contrast-enhanced ultrasound in the diagnosis of tuberous vas deferens tuberculosis.BMC Infect Dis. 2024 Jan 2;24(1):13. doi: 10.1186/s12879-023-08886-6. BMC Infect Dis. 2024. PMID: 38166757 Free PMC article.
-
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition.Breast Cancer. 2024 Mar;31(2):157-164. doi: 10.1007/s12282-023-01521-x. Epub 2023 Nov 16. Breast Cancer. 2024. PMID: 37973686 Free PMC article.
-
The benefits of contrast-enhanced ultrasound in the differential diagnosis of suspicious breast lesions.Front Med (Lausanne). 2024 Dec 24;11:1511200. doi: 10.3389/fmed.2024.1511200. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39776839 Free PMC article.
References
-
- Bonfiglio R, Scimeca M, Toschi N, Pistolese CA, Giannini E, Antonacci C, et al. . Radiological, histological and chemical analysis of breast microcalcifications: diagnostic value and biological significance. J Mammary Gland Biol Neoplasia 2018; 23(1-2): 89–99. doi: 10.1007/s10911-018-9396-0 - DOI - PubMed
-
- Du J, Wang L, Wan C-F, Hua J, Fang H, Chen J, et al. . Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol 2012; 81: 3890–9. doi: 10.1016/j.ejrad.2012.09.004 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical